NEW YORK STATE COMMON RETIREMENT FUND - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$0
-100.0%
348
-98.8%
0.00%
Q1 2023$26
-23.5%
29,0660.0%0.00%
Q4 2022$34
-100.0%
29,066
-0.1%
0.00%
Q3 2022$219,000
+130.5%
29,081
+91.9%
0.00%
Q2 2022$95,000
-24.6%
15,152
-0.3%
0.00%
Q1 2022$126,000
+59.5%
15,203
+0.2%
0.00%
Q4 2021$79,000
-22.5%
15,168
-0.7%
0.00%
Q3 2021$102,000
-55.5%
15,268
-43.2%
0.00%
Q2 2021$229,000
-3.0%
26,862
+0.9%
0.00%
Q1 2021$236,000
-11.6%
26,618
+22.7%
0.00%
Q4 2020$267,000
+107.0%
21,700
+36.5%
0.00%
Q3 2020$129,000
-15.7%
15,9000.0%0.00%
Q2 2020$153,000
+41.7%
15,9000.0%0.00%
Q1 2020$108,000
-69.8%
15,900
-33.8%
0.00%
Q4 2019$358,000
+45.5%
24,0000.0%0.00%
Q3 2019$246,000
-3.1%
24,0000.0%0.00%
Q2 2019$254,000
+309.7%
24,000
+344.4%
0.00%
Q1 2017$62,000
-1.6%
5,401
+0.0%
0.00%
Q4 2016$63,000
-12.5%
5,4000.0%0.00%
Q3 2016$72,000
-32.7%
5,4000.0%0.00%
Q2 2016$107,0005,4000.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 217,029$2,225,0006.42%
Knoll Capital Management, LLC 350,238$3,590,0003.29%
INTERWEST VENTURE MANAGEMENT CO 764,918$7,840,0003.01%
Broadfin Capital, LLC 1,367,377$14,016,0002.59%
P.A.W. CAPITAL CORP 200,000$2,050,0002.56%
683 Capital Management, LLC 1,860,529$19,071,0002.12%
EcoR1 Capital, LLC 1,060,043$10,865,0001.37%
MANGROVE PARTNERS IM, LLC 847,284$8,685,0001.05%
KNOTT DAVID M 234,448$2,403,0001.01%
Trellus Management Company, LLC 85,000$871,0000.87%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders